Standard Process Leaderboard (01-23-2020)

Joint-Skin with Salmon Collagen and Proteoglycans

Share on facebook
Share on twitter

February-Press-Release-Joint-SkinAlameda, CA – Allergy Research Group continues its heritage of bringing innovative nutritional supplements to the professional market with Joint-Skin, the first product of its type on the market.

 
Joint-Skin with Salmon Collagen and Proteoglycans contains SCP-II®, which provides a blend of undenatured Type II collagen and proteoglycans derived from salmon (Oncorhynchus keta) nasal cartilage naturally extracted from an environmentally-friendly source in Japan. It contains no carriers, is non-GMO and non-irradiated. Clinical studies have shown that low doses of Type II collagen and proteoglycans can support improved joint function, mobility, and reduce discomfort.* Proteoglycans have been shown to help increase skin and connective tissue hydration, supporting youthful skin tone, elasticity, and appearance.*

Learn more at www.allergyresearchgroup.com, or 1-800-545-9960, extension 2.

CONTACT:

Dan Mallar, National Sales Director

[email protected]

SCP-II® is a registered trademark of Guzen Development, Inc.

*This statement has not been evaluated by the U.S. Food and Drug administration. The product
is not intended to diagnose, treat, cure, or prevent any disease.